This Medtronic Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Avi Kapoor 13 hours ago
MarketsTrading IdeasPre-Market OutlookNewsUpgrades
Analysts upgraded UNFI, ZBH, NUE, MDT and PRAX, raising price targets and ratings to Buy or Overweight.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Goldman Sachs analyst Leah Jordan upgraded United Natural Foods, Inc. (NYSE:UNFI) from Neutral to Buy and raised the price target from $49 to $60. United Natural Foods closed at $48.39 on Monday. See how other analysts view this stock.
- Wells Fargo analyst Larry Biegelsen upgraded Zimmer Biomet Holdings, Inc. (NYSE:ZBH) from Equal-Weight to Overweight and boosted the price target from $113 to $123. Zimmer Biomet shares closed at $101.41 on Monday. See how other analysts view this stock.
- Morgan Stanley analyst Carlos De Alba upgraded Nucor Corporation (NYSE:NUE) from Equal-Weight to Overweight and increased the price target from $300 to $310. Nucor closed at $252.67 on Monday. See how other analysts view this stock.
- Piper Sandler analyst Matt O’Brien upgraded Medtronic plc (NYSE:MDT) from Neutral to Overweight and raised the price target from $85 to $120. Medtronic shares closed at $102.88 on Monday. See how other analysts view this stock.
- Wells Fargo analyst Benjamin Burnett upgraded Praxis Precision Medicines, Inc. (NASDAQ:PRAX) from Equal-Weight to Overweight and raised the price target from $343 to $509. Praxis Precision Medicine closed at $310.27 on Monday. See how other analysts view this stock.
Considering buying MDT stock? Here’s what analysts think:

Photo via Shutterstock
